Loading…
Reported covered position: (cont'd.) Counsel & Sr.Adv/Cong. Berry
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserving Patient Access to Compounded Medications Act of 2017
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Issues related to health care as they impact compounding pharmacists. H.R.2871 - Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2018 · second_quarter · 2T
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Source: Senate LDA
Issues related to health care as they impact compounding pharmacists. H.R.2871 - Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Issues related to health care as they impact compounding pharmacists. H.R.2871 - Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Issues related to health care as they impact compounding pharmacists. H.R.2871 - Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Issues related to health care as they impact compounding pharmacists. H.R.2871 - Preserving Patient Access to Compounded Medications Act of 2017.
TEST Act of 2015
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
TEST Act of 2015
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
TEST Act of 2015
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
TEST Act of 2015
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
Drug Quality and Security Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
Drug Quality and Security Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
Drug Quality and Security Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
Drug Quality and Security Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
National Desert Storm and Desert Shield War Memorial Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
National Desert Storm and Desert Shield War Memorial Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
National Desert Storm and Desert Shield War Memorial Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
Drug Quality and Security Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
Drug Quality and Security Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
National Desert Storm and Desert Shield War Memorial Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
National Desert Storm and Desert Shield War Memorial Act
Client: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) · Firm: INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
Issues related to health care as they impact compounding pharmacists. H.R.2871 - Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2018 · second_quarter · Q2
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Issues related to health care as they impact compounding pharmacists. H.R.2871 - Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2018 · first_quarter · Q1
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Issues related to health care as they impact compounding pharmacists. H.R.2871 - Preserving Patient Access to Compounded Medications Act of 2017.
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2017 · fourth_quarter · Q4
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Issues related to health care as they impact compounding pharmacists. H.R.2871 - Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2017 · third_quarter · Q3
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Issues related to health care as they impact compounding pharmacists. H.R.2871 - Preserving Patient Access to Compounded Medications Act of 2017.
Issues related to appropriations that would impact compounding pharmacies and pharmacists (no specific bills). Issues related to waste, fraud and abuse of funds and benefits (no specific bills). All FDA/AG appropriations and Omnibus legislation impacting compounding pharmacists. Issues related to the National Defense Authorization Act and TRICARE, drug reimbursements, cost-sharing requirements for pharmacy benefits.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2017 · third_quarter · RA
Issues related to appropriations, Medicare/Medicaid reimbursements, drug pricing, and health care as they relate to compounding pharmacists.
Issues related to appropriations, Medicare/Medicaid reimbursements, drug pricing, and health care as they relate to compounding pharmacists.
Issues related to appropriations, Medicare/Medicaid reimbursements, drug pricing, and health care as they relate to compounding pharmacists.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2015 · fourth_quarter · 4T
Issues related to compounded pharmaceuticals for animals requested by veterinarians. No specific bills.
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
Issues related to the Controlled Substances Act and DEA regulatory activity.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2015 · third_quarter · Q3
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; Issues related to reimbursement for compounding pharmacies (TRICARE and PBMs). Issues related to waste, fraud and abuse of Medicare/Medicaid benefits (No specific bills).
Issues related to the Healthcare Reform Act as they impact compounding pharmacists.
Issues related to appropriations that would impact compounding pharmacies and pharmacists; Issues related to waste, fraud and abuse of funds and benefits. No specific bills.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2015 · second_quarter · Q2
Issues related to the Healthcare Reform Act as they impact compounding pharmacists.
Issues related to appropriations that would impact compounding pharmacies and pharmacists; Issues related to waste, fraud and abuse of funds and benefits. No specific bills.
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2015 · first_quarter · Q1
Issues related to the Healthcare Reform Act as they impact compounding pharmacists.
Issues related to appropriations that would impact compounding pharmacies and pharmacists; Issues related to waste, fraud and abuse of funds and benefits. No specific bills.
Issues related to compounded pharmaceuticals for animals requested by veterinarians. No specific bills.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2014 · fourth_quarter · Q4
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
Issues related to the Healthcare Reform Act as they impact compounding pharmacists.
Issues related to appropriations that would impact compounding pharmacies and pharmacists; Issues related to waste, fraud and abuse of funds and benefits. No specific bills.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2014 · third_quarter · Q3
Issues related to the Healthcare Reform Act as they impact compounding pharmacists.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act.
Issues related to the Controlled Substances Act and DEA regulatory activity.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2014 · second_quarter · Q2
Issues related to the Healthcare Reform Act as they impact compounding pharmacists.
Issues related to the Controlled Substances Act and DEA regulatory activity.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2014 · first_quarter · Q1
Issues related to the Controlled Substances Act and DEA regulatory activity.
Issues related to the Healthcare Reform Act as they impact compounding pharmacists.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2013 · fourth_quarter · 4A
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act.
Issues related to the Healthcare Reform Act as they impact compounding pharmacists.
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) via INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
2013 · fourth_quarter · Q4
Issues related to the Controlled Substances Act and DEA regulatory activity.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act.
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; Issues related to reimbursement for compounding pharmacies (TRICARE and PBMs). Issues related to waste, fraud and abuse of Medicare/Medicaid benefits (No specific bills).
Issues related to the Healthcare Reform Act as they impact compounding pharmacists.
Issues related to appropriations that would impact compounding pharmacies and pharmacists; Issues related to waste, fraud and abuse of funds and benefits. No specific bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to compounded pharmaceuticals for animals requested by veterinarians. No specific bills.
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
Issues related to the Controlled Substances Act and DEA regulatory activity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; Issues related to reimbursement for compounding pharmacies (TRICARE and PBMs). Issues related to waste, fraud and abuse of Medicare/Medicaid benefits (No specific bills).
Issues related to compounded pharmaceuticals for animals requested by veterinarians. No specific bills.
Issues related to the Controlled Substances Act and DEA regulatory activity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to the Controlled Substances Act and DEA regulatory activity.
Legislation related to the implementation of the Food, Drug and Cosmetic Act related to compounding. HR 3204.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; Issues related to reimbursement for compounding pharmacies (TRICARE and PBMs). Issues related to waste, fraud and abuse of Medicare/Medicaid benefits (No specific bills).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to the Controlled Substances Act and DEA regulatory activity.
Issues related to compounded pharmaceuticals for animals requested by veterinarians. No specific bills.
Issues related to Medicare/Medicaid reimbursement of compounded medications and recommended changes to the Social Security Act; Issues related to reimbursement for compounding pharmacies (TRICARE and PBMs). Issues related to waste, fraud and abuse of Medicare/Medicaid benefits (No specific bills).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Legislation related to Compounding Pharmacies and federal reform of the Food, Drug and Cosmetic Act related to compounding. S. 995, HR 3204.
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to the Controlled Substances Act and DEA regulatory activity.
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to the Healthcare Reform Act as they impact compounding pharmacists.
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE